Here’s what you missed on Local 4 News at 5:
FDA begins reviewing data on Pfizer’s COVID vaccine use in children ages 5 to 11 -- Here’s what happens next
The FDA has official begun reviewing data on Pfizer’s COVID-19 vaccine for children ages 5 to 11. Pfizer and it’s partner BioNTech submitted the research Tuesday (Sept. 28) morning -- making a step forward in efforts to vaccinate younger children.
